Eli Lilly: Overvaluation Is A Big Red Flag (NYSE:LLY)
jetcityimage/iStock Editorial via Getty Images Investment thesis Eli Lilly’s (NYSE:LLY) stock is on fire after the massive success of its new drugs aimed at treating diabetes and obesity. The company has a stellar track record of success and will likely continue delivering strong results over the long term. However, my valuation analysis suggests that the…